Ventilatory Dysfunction in Parkinson's Disease

Guillaume Baille, Anna Maria De Jesus, Thierry Perez, David Devos, Kathy Dujardin, Christelle Monaca Charley, Luc Defebvre, Caroline Moreau, Guillaume Baille, Anna Maria De Jesus, Thierry Perez, David Devos, Kathy Dujardin, Christelle Monaca Charley, Luc Defebvre, Caroline Moreau

Abstract

In contrast to some other neurodegenerative diseases, little is known about ventilatory dysfunction in Parkinson's disease (PD). To assess the spectrum of ventilation disorders in PD, we searched for and reviewed studies of dyspnea, lung volumes, respiratory muscle function, sleep breathing disorders and the response to hypoxemia in PD. Among the studies, we identified some limitations: (i) small study populations (mainly composed of patients with advanced PD), (ii) the absence of long-term follow-up and (iii) the absence of functional evaluations under "off-drug" conditions. Although there are many reports of abnormal spirometry data in PD (mainly related to impairment of the inspiratory muscles), little is known about hypoventilation in PD. We conclude that ventilatory dysfunction in PD has been poorly studied and little is known about its frequency and clinical relevance. Hence, there is a need to characterize the different phenotypes of ventilation disorders in PD, study their relationships with disease progression and assess their prognostic value.

Keywords: Parkinson’s disease; pathophysiology; review; ventilatory function.

Figures

Fig.1
Fig.1
A flow-volume loop in a PD patient (personal observation). Ordinate: Flow (L/s), Abscissa: Volume (L). Ventilatory flutter is predominant during inspiration (black arrow).

References

    1. Troussière A-C, Charley CM, Salleron J, Richard F, Delbeuck X, Derambure P, Pasquier F, & Bombois S (2014) Treatment of sleep apnoea syndrome decreases cognitive decline in patients with Alzheimer’s disease. J Neurol Neurosurg Psychiatry, 12, 1405–1408.
    1. Kim S-M, Kim H, Lee J-S, Park KS, Jeon GS, Shon J, Ahn SW, Kim SH, Lee KM, Sung JJ, & Lee KW (2013) Intermittent hypoxia can aggravate motor neuronal loss and cognitive dysfunction in ALS mice. PLoS One, 11, e81808.
    1. Moreau C, Devos D, Gosset P, Brunaud-Danel V, Tonnel AB, Lassalle P, Defebvre L, & Destée A (2010) Mechanisms of deregulated response to hypoxia in sporadic amyotrophic lateral sclerosis: A clinical study. Rev Neurol (Paris), 3, 279–283.
    1. Burns JM, Cronk BB, Anderson HS, Donnelly JE, Thomas GP, Harsha A, Brooks WM, & Swerdlow RH (2008) Cardiorespiratory fitness and brain atrophy in early Alzheimer disease. Neurology, 3, 210–216.
    1. Parkinson J (2002) An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci, 2, 223–236.
    1. Ebihara S, Saito H, Kanda A, Nakajoh M, Takahashi H, Arai H, & Sasaki H (2003) Impaired efficacy of cough in patients with Parkinson disease. Chest, 3, 1009–1015.
    1. Fontana GA, Pantaleo T, Lavorini F, Maluccio NM, Mutolo D, & Pistolesi M (1998) Defective motor control of coughing in Parkinson’s disease. Am J Respir Crit Care Med, 2, 458–464.
    1. Mehanna R, & Jankovic J (2010) Respiratory problems in neurologic movement disorders. Parkinsonism Relat Disord, 10, 628–638.
    1. Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, Calverley PM, Gift AG, Harver A, Lareau SC, Mahler DA, Meek PM, & O’Donnell DE; American Thoracic Society Committee on Dyspnea (2012) An official American Thoracic Society statement: Update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med, 4, 435–452.
    1. Chenivesse C, Chan P-Y, Tsai H-W, Wheeler-Hegland K, Silverman E, von Leupoldt A, Similowski T, Davenport P (2014) Negative emotional stimulation decreases respiratory sensory gating in healthy humans. Respir Physiol Neurobiol, 204, 50–57.
    1. Ho SF, O’Mahony MS, Steward JA, Breay P, Buchalter M, & Burr ML (2001) Dyspnoea and quality of life in older people at home. Age Ageing, 2, 155–159.
    1. Yust-Katz S, Shitrit D, Melamed E, & Djaldetti R (2012) Respiratory distress: An unrecognized non-motor phenomenon in patients with parkinsonism. J Neural Transm, 1, 73–76.
    1. Susan HF, & Lang AE (2007) Motor and nonmotor fluctuations. Handbook of Clinical Neurology Elsevier, Edinburgh–Toronto, pp. 159–184.
    1. Witjas T, Kaphan E, Azulay JP, Blin O, Ceccaldi M, Pouget J, Poncet M, & Chérif AA (2002) Nonmotor fluctuations in Parkinson’s disease: Frequent and disabling. Neurology, 3, 408–413.
    1. Weiner P, Inzelberg R, Davidovich A, Nisipeanu P, Magadle R, Berar-Yanay N, & Carasso RL (2002) Respiratory muscle performance and the Perception of dyspnea in Parkinson’s disease. Can J Neurol Sci, 1, 68–72.
    1. Onodera H, Okabe S, Kikuchi Y, Tsuda T, & Itoyama Y (2000) Impaired chemosensitivity and perception of dyspnoea in Parkinson’s disease. Lancet, 9231, 739–740.
    1. Storch A, Schneider CB, Wolz M, Stürwald Y, Nebe A, Odin P, Mahler A, Fuchs G, Jost WH, Chaudhuri KR, Koch R, Reichmann H, & Ebersbach G (2013) Nonmotor fluctuations in Parkinson disease: Severity and correlation with motor complications. Neurology, 9, 800–809.
    1. Leentjens AFG, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, & Starkstein SE (2012) Anxiety and motor fluctuations in Parkinson’s disease: A cross-sectional observational study. Parkinsonism Relat Disord, 10, 1084–1088.
    1. Bayulkem K, & Lopez G (2010) Nonmotor fluctuations in Parkinson’s disease: Clinical spectrum and classification. J Neurol Sci, 1-2, 89–92.
    1. Martinez JA, Rocha FS, Sobrani E, Galhardo FP, & Terra Filho J (2002) Effects of ondansetron on respiratory pattern and sensation of experimentally induced dyspnea. Sao Paulo Med J, 5, 141–145.
    1. Kallas de Carvalho F, Filho JT, Vianna EO, Silva GA, Martinez JA (2002) Do steroids interfere in dyspnoea sensation? Respir Med, 7, 511–514.
    1. Rice JE, Antic R, & Thompson PD (2002) Disordered respiration as a levodopa-induced dyskinesia in Parkinson’s disease. Mov Disord, 3, 524–527.
    1. Chalif JI, Sitsapesan HA, Pattinson KTS, Herigstad M, Aziz TZ, & Green AL (2014) Dyspnea as a side effect of subthalamic nucleus deep brain stimulation for Parkinson’s disease. Respir Physiol Neurobiol, 192, 128–133.
    1. Yanase M, Kataoka H, Kawahara M, Hirabayashi H, Yamanaka T, Hirano M, & Ueno S (2008) Fixed epiglottis associated with subthalamic nucleus stimulation inParkinson’s disease. J Neurol Neurosurg Psychiatry, 3, 332–333.
    1. De Pandis MF, Starace A, Stefanelli F, Marruzzo P, Meoli I, De Simone G, Prati R, & Stocchi F (2002) Modification of respiratory function parameters in patients with severe Parkinson’s disease. Neurol Sci Suppl, 2, 69–70.
    1. Wang Y, Shao WB, Gao L, Lu J, Gu H, Sun LH, Tan Y, & Zhang YD (2014) Abnormal pulmonary function and respiratory muscle strength findings in Chinese patients with Parkinson’s disease and multiple system atrophy–comparison with normal elderly. PLoS One, 12, e116123.
    1. Cardoso SRX, & Pereira JS (2002) Analysis of breathing function in Parkinson’s disease. Arq Neuropsiquiatr, 1, 91–95.
    1. Izquierdo-Alonso JL, Jiménez-Jiménez FJ, Cabrera-Valdivia F, & Mansilla-Lesmes M (1994) Airway dysfunction in patients with Parkinson’s disease. Lung, 1, 47–55.
    1. Pal PK, Sathyaprabha TN, Tuhina P, & Thennarasu K (2007) Pattern of subclinical pulmonary dysfunctions inParkinson’s disease and the effect of levodopa. Mov Disord, 3, 420–424.
    1. Sabaté M, González I, Ruperez F, & Rodríguez M (1996) Obstructive and restrictive pulmonary dysfunctions in Parkinson’s disease. J Neurol Sci, 1-2, 114–119.
    1. Murdoch BE, Chenery HJ, Bowler S, & Ingram JC (1989) Respiratory function in Parkinson’s subjects exhibiting a perceptible speech deficit: A kinematic and spirometric analysis. J Speech Hear Disord, 4, 610–626.
    1. Hovestadt A, Bogaard JM, Meerwaldt JD, van der Meché FG, & Stigt J (1989) Pulmonary function in Parkinson’s disease. J Neurol Neurosurg Psychiatr, 3, 329–333.
    1. Vincken WG, Gauthier SG, Dollfuss RE, Hanson RE, Darauay CM, & Cosio M (1984) Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow limitation. N Engl J Med, 7, 438–442.
    1. Nakano KK, Bass H, & Tyler HR (1972) Levodopa in Parkinson’s disease: Effect on pulmonary function. Arch Intern Med, 3, 346–348.
    1. Herer B, Arnulf I, & Housset B (2001) Effects of levodopa on pulmonary function in Parkinson’s disease. Chest, 2, 387–393.
    1. Bateman DN, Cooper RG, Gibson GJ, Peel ET, & Wandless I (1981) Levodopa dosage and ventilatory function in Parkinson’s disease. Br Med J (Clin Res Ed), 6285, 190–191.
    1. Obenour WH, Stevens PM, Cohen AA, & McCutchen JJ (1972) The causes of abnormal pulmonary function in Parkinson’s disease. Am Rev Respir Dis, 3, 382–387.
    1. Sathyaprabha TN, Kapavarapu PK, Pall PK, Thennarasu K, & Raju TR (2005) Pulmonary functions in Parkinson’s disease. Indian J Chest Dis Allied Sci, 4, 251–257.
    1. Haas BM, Trew M, & Castle PC (2004) Effects of respiratory muscle weakness on daily living function, quality of life, activity levels, and exercise capacity in mild to moderate Parkinson’s disease. Am J Phys Med Rehabil, 8, 601–607.
    1. Tzelepis GE, McCool FD, Friedman JH, & Hoppin FG Jr (1988) Respiratory muscle dysfunction in Parkinson’sdisease. Am Rev Respir Dis, 2, 266–271.
    1. Guedes LU, Rodrigues JM, Fernandes AA, Cardoso FE, & Parreira VF (2012) Respiratory changes in Parkinson’s disease may be unrelated to dopaminergic dysfunction. Arq Neuropsiquiatr, 11, 847–851.
    1. De Bruin PF, de Bruin VM, Lees AJ, & Pride NB (1993) Effects of treatment on airway dynamics and respiratory muscle strength in Parkinson’s disease. Am Rev Respir Dis, 6, 1576–1580.
    1. Brown P, Corcos DM, & Rothwell JC (1997) Does parkinsonian action tremor contribute to muscle weakness in Parkinson’s disease? Brain, 3, 401–408.
    1. Estenne M, Hubert M, & De Troyer A (1984) Respiratory-muscle involvement in Parkinson’s disease. N Engl J Med, 23, 1516–1517.
    1. Vercueil L, Linard JP, Wuyam B, Pollak P, & Benchetrit G (1999) Breathing pattern in patients with Parkinson’s disease. Respir Physiol, 2-3, 163–172.
    1. Polatli M, Akyol A, Cildag O, & Bayülkem K (2001) Pulmonary function tests in Parkinson’s disease. Eur J Neurol, 4, 341–345.
    1. Da Silva-Júnior FP, do Prado GF, Barbosa ER, Tufik S, & Togeiro SM (2014) Sleep disordered breathing in Parkinson’s disease: A critical appraisal. Sleep Med Rev, 2, 173–178.
    1. Shill H, & Stacy M (1998) Respiratory function inParkinson’s disease. Clin Neurosci, 2, 131–135.
    1. Maria B, Sophia S, Michalis M, Charalampos L, Andreas P, John ME, & Nikolaos SM (2003) Sleep breathing disorders in patients with idiopathic Parkinson’s disease. Respir Med, 10, 1151–1157.
    1. Diederich NJ, Vaillant M, Leischen M, Mancuso G, Golinval S, Nati R, & Schlesser M (2005) Sleep apnea syndrome in Parkinson’s disease. A case-control study in 49 patients. Mov Disord, 11, 1413–1418.
    1. Trotti LM, & Bliwise DL (2010) No increased risk of obstructive sleep apnea in Parkinson’s disease. Mov Disord, 13, 2246–2249.
    1. Valko P, Hauser S, Sommerauer M, Werth E, & Baumann CR (2014) Observations on sleep-disordered breathing in idiopathic Parkinson’s disease. PLoS One, 6, e100828.
    1. Joy SP, Sinha S, Pal PK, Panda S, Philip M, & Taly AB (2014) Alterations in Polysomnographic (PSG) profile in drug-naïve Parkinson’s disease. Ann Indian Acad Neurol, 3, 287–291.
    1. Monaca C, Duhamel A, Jacquesson JM, Ozsancak C, Destée A, Guieu JD, Defebvre L, & Derambure P (2006) Vigilance troubles in Parkinson’s disease: A subjective and objective polysomnographic study. Sleep Med, 5, 448–453.
    1. Trotti LM, & Bliwise DL (2014) Treatment of the sleep disorders associated with Parkinson’s disease. Neurotherapeutics, 1, 68–77.
    1. Serebrovskaya T, Karaban I, Mankovskaya I, Bernardi L, Passino C, & Appenzeller O (1998) Hypoxic ventilatory responses and gas exchange in patients with Parkinson’s disease. Respiration, 1, 28–33.
    1. Seccombe LM, Rogers PG, Hayes MW, Farah CS, Veitch EM, & MJ (2013) Reduced hypoxic sympathetic response in mild Parkinson’s disease: Further evidence of early autonomic dysfunction. Parkinsonism Relat Disord, 11, 1066–1068.
    1. Seccombe LM, Giddings HL, Rogers PG, Corbett AJ, Hayes MW, Peters MJ, & Veitch EM (2011) Abnormal ventilatory control in Parkinson’s disease–further evidence for non-motor dysfunction. Respir Physiol Neurobiol, 2-3, 300–304.
    1. Diederich NJ, & McIntyre DJ (2012) Sleep disorders in Parkinson’s disease: Many causes, few therapeutic options. J Neurol Sci, 1-2, 12–19.
    1. Braak H, Del Tredici K, Rüb U, Rüb U, de Vos RA, Jansen Steur EN, & Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging, 2, 197–211.
    1. Olanow CW (2007) The pathogenesis of cell death in Parkinson’s disease. Mov Disord Suppl, 17, S342–S335.
    1. Gama RL, Távora DG, Bomfim RC, Silva CE, de Bruin VM, & de Bruin PF (2010) Sleep disturbances and brain MRI morphometry in Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy - a comparative study. Parkinsonism Relat Disord, 4, 275–279.
    1. Yaffe K, Laffan AM, Harrison SL, Redline S, Spira AP, Ensrud KE, Ancoli-Israel S, & Stone KL (2011) Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA, 6, 613–619.
    1. Neikrug AB, Maglione JE, Liu L, Natarajan L, Avanzino JA, Corey-Bloom J, Palmer BW, Loredo JS, & Ancoli-Israel S (2013) Effects of sleep disorders on the non-motor symptoms of Parkinson disease. J Clin Sleep Med, 11, 1119–1129.
    1. Uc EY, McDermott MP, Marder KS, Anderson SW, Litvan I, Como PG, Auinger P, Chou KL, & Growdon JC; Parkinson Study Group DATATOP Investigators (2009) Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort. Neurology, 18, 1469–1477.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir